Price $1.80 |
Market Cap
22.7M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
173.81
|
P/S
12.71
|
Dividend %
-
|
|
P/CF
298.1
|
P/FCF
-
|
Op. Cash Flow
-5K
|
FCF
-0.4
|
|
Op. Margin
-296.80%
|
Net Margin
-252.20%
|
ROE
-267.80%
|
ROI
-254.60%
|
|
ROA
-50.20%
|
EPS Growth
39.50%
|
Current Ratio
4.4
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Navidea Biopharmaceuticals Inc (NAVB) | $0.33 | - | - | 39.3M | Strong Buy |
| Vaxart Inc (VXRT) | $3.20 | - | - | 20.3M | Strong Buy |
| Altimmune Inc (ALT) | $4.65 | - | - | 17.4M | Strong Buy |
| Civitas Solutions Inc (CIVI) | $15.78 | - | - | 527.1M | Strong Buy |
| Allied Healthcare Products Inc (AHPI) | $2.09 | - | - | 8.8M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
